Last --
Change Today 0.00 / 0.00%
Volume 0.0
1093 On Other Exchanges
Symbol
Exchange
1093 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

cspc pharmaceutical group lt (1093) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CSPC PHARMACEUTICAL GROUP LT (1093)

Related News

No related news articles were found.

cspc pharmaceutical group lt (1093) Related Businessweek News

No Related Businessweek News Found

cspc pharmaceutical group lt (1093) Details

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It offers finished drugs, including NBP series primarily for the acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning principally for hypertension; Duomeisu, a chemotherapy drug; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; and Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion. The company also provides generic drugs, antibiotics, vitamin C products, and caffeine and other drugs. In addition, it researches and develops approximately 170 products for therapeutic areas of anti-infective, cardio-cerebrovascular, diabetes, neurology, and oncology. Further, the company offers pharmaceutical research and development services; and sewage treatment services. It has operations primarily in the People’s Republic of China, other Asian regions, the Americas, and Europe. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. The company is based in Wan Chai, Hong Kong and is considered a Red Chip company due to its listing on the Hong Kong Stock Exchange.

10,390 Employees
Last Reported Date: 04/9/14

cspc pharmaceutical group lt (1093) Top Compensated Officers

Executive Chairman, Chief Executive Officer, ...
Total Annual Compensation: $10.8M
Executive Director
Total Annual Compensation: $3.9M
Executive Director
Total Annual Compensation: $760.0K
Executive Director
Total Annual Compensation: $760.0K
Executive Director
Total Annual Compensation: $760.0K
Compensation as of Fiscal Year 2013.

cspc pharmaceutical group lt (1093) Key Developments

CSPC Pharmaceutical Group Limited Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2014

CSPC Pharmaceutical Group Limited reported unaudited consolidated earnings results for the nine months ended September 30, 2014. For the period, the company reported revenue of HKD 8,138,631,000 compared to HKD 7,432,810,000 a year ago. Profit attributable to shareholders was HKD 920,371,000 or 15.42 cents per diluted share compared to HKD 759,131,000 or 12.93 cents per diluted share a year ago. Operating profit was HKD 1,227,279,000 compared to HKD 867,827,000 a year ago. Profit before taxation was HKD 1,184,232,000 compared to HKD 952,728,000 a year ago.

CSPC Pharmaceutical Group Limited to Report Q3, 2014 Results on Nov 25, 2014

CSPC Pharmaceutical Group Limited announced that they will report Q3, 2014 results on Nov 25, 2014

CSPC Pharmaceutical Group Limited Presents at Citi China Investor Conference 2014, Nov-04-2014

CSPC Pharmaceutical Group Limited Presents at Citi China Investor Conference 2014, Nov-04-2014 . Venue: Grand Hyatt, Macau, China. Speakers: Eddie Chak, Executive Director, Winnie Yam, IR Manager.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1093:HK $6.56 HKD +0.01

1093 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1093.
View Industry Companies
 

Industry Analysis

1093

Industry Average

Valuation 1093 Industry Range
Price/Earnings 34.5x
Price/Sales 3.6x
Price/Book 5.2x
Price/Cash Flow 34.2x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSPC PHARMACEUTICAL GROUP LT, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.